Related references
Note: Only part of the references are listed.Primary hyperlipidemia
Tamio Teramoto et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial
Michiel L. Bots et al.
LANCET (2007)
Identification of IKr and its trafficking disruption induced by probucol in cultured neonatal rat cardiomyocytes
Jun Guo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia
John J. P. Kastelein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effect of torcetrapib on the progression of coronary atherosclerosis
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Statins and cancer risk: A literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials
Stefanos Bonovas et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
Haruo Nakamura et al.
LANCET (2006)
Mechanisms of disease: proatherogenic HDL - an evolving field
Mohamad Navab et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2006)
Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism
K Hirano et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease
S Tsimikas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Drug treatment of hyperlipidemia in women
JME Walsh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Effects of AGI-1067 and probucol after percutaneous coronary interventions
JC Tardif et al.
CIRCULATION (2003)
Comparison of the effects of α-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits
JH Bräsen et al.
ATHEROSCLEROSIS (2002)
Effects of Probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia - Fukuoka Atherosclerosis Trial (FAST)
Y Sawayama et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART])
H Daida et al.
AMERICAN JOURNAL OF CARDIOLOGY (2000)
Share Paper
